Dovitinib Dilactic acid (TKI258 Dilactic acid)
目录号: A10198
RTK 抑制剂
Dovitinib 是一种小分子多靶点受体酪氨酸激酶抑制剂,它能够抑制通过 ZNF198-FGFR1 或 BCR-FGFR1 转化为 IL3 独立的 Ba/F3 细胞,其 IC50 值分别为 150 nM 和 90 nM。
| Discription | Dovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively. | ||
|---|---|---|---|
| Targets |
|
| 目录号 | A10198 |
|---|---|
| 分子式 | C21H21FN6O.2C3H6O3 |
| 分子量 | 572.6 |
| CAS号 | 852433-84-2 |
| SMILES | CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C/4\C(=C5C(=NC4=O)C=CC=C5F)N)/N3 |
| 其他名称 | CHIR-258 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2